Executive Overview For decades, the standard management of high-risk acute promyelocytic leukemia (APL)—defined by a presenting white blood cell (WBC)...
Published: June 10, 2026 | Frontiers in Hematology Executive Overview For more than half a century, cytotoxic chemotherapy has offered...
Executive Overview For decades, disease relapse following allogeneic hematopoietic cell transplantation (allo-HCT) has represented one of the most formidable and...
A landmark global study has cast a long-overdue spotlight on the profound psychological, emotional, and social strain shouldered by informal...
In the intricate landscape of hematologic oncology, thrombotic complications are a recognized, albeit dreaded, hazard. Usually emerging in the crucible...
Acute myeloid leukemia (AML) has long stood as one of the most aggressive and formidable blood cancers known to modern...
Executive Overview Sickle cell disease (SCD) remains one of the world’s most pervasive and challenging inherited blood disorders, characterized by...
Executive Overview Blood transfusions remain a cornerstone in the management of sickle cell anemia (SCA), acting as a vital intervention...
A comprehensive new real-world observational study utilizing United States administrative claims data has revealed that adults living with non-transfusion-dependent thalassemia...
Executive Overview Polycythemia Vera (PV) and related Philadelphia-negative myeloproliferative neoplasms (MPNs)—such as essential thrombocythemia (ET) and myelofibrosis (MF)—represent a complex...
Executive Overview In the realm of rare hematology, the convergence of multiple complex pathologies presents an extraordinary diagnostic and therapeutic...
Executive Overview In the intricate landscape of hematology, pancytopenia—a dangerous reduction in red blood cells, white blood cells, and platelets—serves...